<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01771939</url>
  </required_header>
  <id_info>
    <org_study_id>VTCMER2</org_study_id>
    <nct_id>NCT01771939</nct_id>
  </id_info>
  <brief_title>Phacoemulsification and 25 Gauge (25G) Vitrectomy Versus Phacoemulsification Only in Idiopathic Epiretinal Membranes</brief_title>
  <official_title>Morphologic and Functional Results After Phacoemulsification and 25 Gauge Vitrectomy Versus Phacoemulsification Only in Eyes Affected by Idiopathic Epiretinal Membranes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Turin, Italy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Turin, Italy</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to evaluate the difference in Early Treatment Diabetic
      Retinopathy Study (ETDRS) visual acuity, oct retinal thickness and microperimetry in 2 groups
      of 30 eyes each affected by idiopathic epiretinal membranes that underwent
      phacoemulsification and 25G pars-plana vitrectomy with internal limiting membrane (ILM)
      peeling (Group 1) versus phacoemulsification only (Group 2), with a follow-up length up to 5
      years.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Idiopathic epiretinal membranes represent a common cause of visual loss in elderly
      population. Vitrectomy with membrane peeling is nowadays considered the gold standard in the
      management of such pathology, with very good results either at short-time or at long-time
      follow up. In case of mild visual impairment due to epiretinal membrane and associated
      cataract, it is reasonable to treat only the lens pathology (with phacoemulsification and
      intra-ocular lens (IOL) implantation). In case of symptoms or ophthalmoscopic finding
      worsening it is always possible to submit patients who only underwent cataract surgery to
      vitrectomy with membrane peeling. There are, by now, no comparative studies between these two
      different approaches in medical literature.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2006</start_date>
  <completion_date type="Actual">July 2012</completion_date>
  <primary_completion_date type="Actual">November 2006</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual acuity (using LogMar scale) changes from baseline to pre-defined periods after surgery</measure>
    <time_frame>within 90,180,360,1360 days after surgery</time_frame>
    <description>We observed how did the visual acuity (using LogMar scale) increase after the two different surgical approaches described.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Microperimetry parameters and average macular thickness changes</measure>
    <time_frame>within 90,180,360,1360 days after surgery</time_frame>
    <description>We evaluated average sensitivity (SM) and local defect (DL) using microperimetry. We also evaluated the average macular thickness using optical coherence tomography technology.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Epiretinal Membrane</condition>
  <arm_group>
    <arm_group_label>idiopathic epiretinal membranes</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in first arm, with worse visual condition, treated with 25-G Vitrectomy and phacoemulsification (cataract intervention)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>idiopathic epiretinal membrane</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patient in second arm, with better pre-operative condition, treated with phacoemulsification (cataract intervention) only</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>25-G vitrectomy and phacoemulsification</intervention_name>
    <description>25-G vitrectomy with Internal Limiting Membrane peeling and phacoemulsification (cataract intervention)</description>
    <arm_group_label>idiopathic epiretinal membranes</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>phacoemulsification (cataract surgery)</intervention_name>
    <description>lens extraction after phacoemulsification and intra-ocular artificial lens implantation</description>
    <arm_group_label>idiopathic epiretinal membrane</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Idiopathic epiretinal membranes symptomatic

        Exclusion Criteria:

          -  Absence of ocular symptoms, previous retinal interventions
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marco Dal Vecchio, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinica Oculistica dell'Università, Ospedale Oftalmico Turin, Italy 10100</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antonio M. Fea, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Clinica Oculistica dell'Università, Ospedale Oftalmico Turin, Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Carlo A Lavia, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinica Oculistica dell'Università, Ospedale Oftalmico Turin, Italy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinica Oculistica dell'Università, Ospedale Oftalmico</name>
      <address>
        <city>Turin</city>
        <zip>10100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 13, 2012</study_first_submitted>
  <study_first_submitted_qc>January 16, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 18, 2013</study_first_posted>
  <last_update_submitted>January 16, 2013</last_update_submitted>
  <last_update_submitted_qc>January 16, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 18, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Turin, Italy</investigator_affiliation>
    <investigator_full_name>Marco Dal Vecchio</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Idiopathic epiretinal membranes</keyword>
  <keyword>25-G surgery in idiopathic epiretinal membranes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epiretinal Membrane</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

